ClinicalTrials.Veeva

Menu

Testing of an Interface for Synchronizing tACS-DBS With a Phase-locked-loop

U

Universitätsklinikum Hamburg-Eppendorf

Status

Enrolling

Conditions

Parkinson's Disease (PD)
Deep Brain Stimulation

Treatments

Device: DBS-coupled tACS

Study type

Interventional

Funder types

Other

Identifiers

NCT07139093
PV7207_1
SCHW 2023/2-1 (Other Grant/Funding Number)

Details and patient eligibility

About

The investigators aim to test an interface to phase-lock transcranial alternating current stimulation (tACS) and deep brain stimulation (DBS) for future studies investigating the effects of different time-lags between DBS and tACS on the behavioural and neural level. To test if the interface works in patients with DBS, the investigators record EEG during synchronized tACS-DBS in several patients. The investigators hypothesize that they can apply tACS at the desired phase-lags relative to DBS pulses and confirm this with EEG measurements of the DBS and tACS artifact.

Enrollment

2 estimated patients

Sex

All

Ages

35 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Provision of written informed consent by the patient
  • Age 35 - 85
  • patient groups: Parkinson's disease, essential tremor, dystonia
  • >3 months after surgery for DBS

Exclusion criteria

  • Epilepsy or history of seizures
  • Existence of heart pacemaker or other metal implants in the body (except DBS)
  • Pregnancy

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

2 participants in 1 patient group

phase-lags
Experimental group
Description:
Device: phase-lags * DBS will be applied at a fixed frequency between 15-30 Hz in one hemisphere only using the contact(s) of the clinical DBS settings. The amplitude of the electrode in the other hemisphere will be set to 0mA. * tACS will be applied closed-loop at the same frequency as DBS; with 4 phase lags relative to the DBS pulse (0°, 90°, 180°, 270°). tACS will be administered using the neuroConn DC-STIMULATOR PLUS. * EEG will be measured during this intervention with an analog (Digitimer) amplifier.
Treatment:
Device: DBS-coupled tACS

Trial contacts and locations

1

Loading...

Central trial contact

Bettina C. Schwab, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems